804 related articles for article (PubMed ID: 20080689)
1. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
2. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression.
Song H; Mak KK; Topol L; Yun K; Hu J; Garrett L; Chen Y; Park O; Chang J; Simpson RM; Wang CY; Gao B; Jiang J; Yang Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1431-6. PubMed ID: 20080598
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1.
Zhang X; Guo C; Wu X; Li AX; Liu L; Tsark W; Dammann R; Shen H; Vonderfecht SL; Pfeifer GP
Cancer Res; 2016 May; 76(9):2824-35. PubMed ID: 26980762
[TBL] [Abstract][Full Text] [Related]
4. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
[TBL] [Abstract][Full Text] [Related]
5. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
[TBL] [Abstract][Full Text] [Related]
7. A breakdown of the Hippo pathway in gastric cancer.
Xu ZP; Zhu JS; Zhang Q; Wang XY
Hepatogastroenterology; 2011; 58(110-111):1611-7. PubMed ID: 21940329
[TBL] [Abstract][Full Text] [Related]
8. Mammalian sterile 20 kinase 1 and 2 are important regulators of hematopoietic stem cells in stress condition.
Lee DH; Kim TS; Lee D; Lim DS
Sci Rep; 2018 Jan; 8(1):942. PubMed ID: 29343826
[TBL] [Abstract][Full Text] [Related]
9. RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.
Yin H; Bogorad RL; Barnes C; Walsh S; Zhuang I; Nonaka H; Ruda V; Kuchimanchi S; Nechev L; Akinc A; Xue W; Zerial M; Langer R; Anderson DG; Koteliansky V
J Hepatol; 2016 Apr; 64(4):899-907. PubMed ID: 26658687
[TBL] [Abstract][Full Text] [Related]
10. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
Patel SH; Camargo FD; Yimlamai D
Gastroenterology; 2017 Feb; 152(3):533-545. PubMed ID: 28003097
[TBL] [Abstract][Full Text] [Related]
11. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation.
Praskova M; Xia F; Avruch J
Curr Biol; 2008 Mar; 18(5):311-21. PubMed ID: 18328708
[TBL] [Abstract][Full Text] [Related]
12. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
13. Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2.
Loforese G; Malinka T; Keogh A; Baier F; Simillion C; Montani M; Halazonetis TD; Candinas D; Stroka D
EMBO Mol Med; 2017 Jan; 9(1):46-60. PubMed ID: 27940445
[TBL] [Abstract][Full Text] [Related]
14. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
[TBL] [Abstract][Full Text] [Related]
15. Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.
Shi H; Liu C; Tan H; Li Y; Nguyen TM; Dhungana Y; Guy C; Vogel P; Neale G; Rankin S; Feng Y; Peng J; Tao W; Chi H
Immunity; 2018 Nov; 49(5):899-914.e6. PubMed ID: 30413360
[TBL] [Abstract][Full Text] [Related]
16. Functional role of Mst1/Mst2 in embryonic stem cell differentiation.
Li P; Chen Y; Mak KK; Wong CK; Wang CC; Yuan P
PLoS One; 2013; 8(11):e79867. PubMed ID: 24224013
[TBL] [Abstract][Full Text] [Related]
17. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
18. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096
[TBL] [Abstract][Full Text] [Related]
19. Mammalian Hippo kinase pathway is downregulated by BCL-2 via protein degradation.
Won GW; Park SH; Park J; Lee Y; Lee YH
Biochem Biophys Res Commun; 2019 Apr; 512(1):87-92. PubMed ID: 30867124
[TBL] [Abstract][Full Text] [Related]
20. Tubule-Specific Mst1/2 Deficiency Induces CKD
Xu C; Wang L; Zhang Y; Li W; Li J; Wang Y; Meng C; Qin J; Zheng ZH; Lan HY; Mak KK; Huang Y; Xia Y
J Am Soc Nephrol; 2020 May; 31(5):946-961. PubMed ID: 32253273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
